Gamma Valerolactone Market Size(US$)

CAGR 2024-2030
-0.3%
Market Size,2030
USD 729.3
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Gamma Valerolactone (CAS 108-29-2) is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.
The global Gamma Valerolactone market size was US$ 745 million in 2023 and is forecast to a readjusted size of US$ 729.3 million by 2030 with a CAGR of -0.3% during the forecast period 2024-2030.
Global Gamma Valerolactone (CAS 108-29-2) key players include Anhui Hyea Aromas, Dideu Industries, Kunshan Qiandeng Baihua, etc. Global top three manufacturers hold a share over 75%.
China is the largest market, with a share over 85%, followed by Japan, and USA, both have a share about 10 percent.
In terms of product, Food Grade is the largest segment, with a share nearly 75%. And in terms of application, the largest application is Food Flavors, followed by Monomer Intermediate, Solvents, etc.
In terms of production side, this report researches the Gamma Valerolactone capacity, production, growth rate, market share by manufacturers, region level and country level, from 2019 to 2024, and forecast to 2030.
In terms of sales (consumption) side, this report focuses on the sales of Gamma Valerolactone by region (Countries), company, type and application. from 2019 to 2024 and forecast to 2030.
The global Gamma Valerolactone market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by type segment of the global Gamma Valerolactone market. These figures have been provided in terms of both revenue and volume for the period 2019-2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Gamma Valerolactone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Gamma Valerolactone production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 4: Detailed analysis of Gamma Valerolactone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 9: China by company, by type and by application, sales, and revenue for each segment.
Chapter 10: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gamma Valerolactone sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Gamma Valerolactone Definition
1.2 Market by Type
1.2.1 Global Gamma Valerolactone Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Food Grade
1.2.3 Industrial Grade
1.3 Market by Application
1.3.1 Global Gamma Valerolactone Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Food Flavors
1.3.3 Solvent
1.3.4 Monomer Intermediate
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Gamma Valerolactone Sales
2.1 Global Gamma Valerolactone Revenue Estimates and Forecasts 2019-2030
2.2 Global Gamma Valerolactone Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Gamma Valerolactone Revenue by Region
2.3.1 Global Gamma Valerolactone Revenue by Region (2019-2024)
2.3.2 Global Gamma Valerolactone Revenue by Region (2025-2030)
2.4 Global Gamma Valerolactone Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Gamma Valerolactone Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Gamma Valerolactone Sales Quantity by Region
2.6.1 Global Gamma Valerolactone Sales Quantity by Region (2019-2024)
2.6.2 Global Gamma Valerolactone Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Global Production (Based on Production Site)
3.1 Global Gamma Valerolactone Production Value by Region: 2019 VS 2023 VS 2030
3.2 Global Gamma Valerolactone Production Value by Region
3.2.1 Global Gamma Valerolactone Historic Production Value by Region (2019-2024)
3.2.2 Global Gamma Valerolactone Forecasted Production Value by Region (2025-2030)
3.3 Global Gamma Valerolactone Production Capacity (2019-2030)
3.4 Global Gamma Valerolactone Production by Region: 2019 VS 2023 VS 2030
3.5 Global Gamma Valerolactone Production by Region
3.5.1 Global Gamma Valerolactone Historic Production by Region (2019-2024)
3.5.2 Global Gamma Valerolactone Forecasted Production by Region (2025-2030)
3.5.3 North America
3.5.4 Europe
3.5.5 Japan
3.5.6 China
3.5.7 South Korea
3.5.8 India
4 Competition by Manufacturers
4.1 Global Gamma Valerolactone Sales Quantity by Manufacturers
4.1.1 Global Gamma Valerolactone Sales Quantity by Manufacturers (2019-2024)
4.1.2 Global Gamma Valerolactone Sales Quantity Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Companies by Gamma Valerolactone Sales in 2023
4.2 Global Gamma Valerolactone Revenue by Manufacturers
4.2.1 Global Gamma Valerolactone Revenue by Manufacturers (2019-2024)
4.2.2 Global Gamma Valerolactone Revenue Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Gamma Valerolactone Revenue in 2023
4.3 Global Gamma Valerolactone Sales Price by Manufacturers
4.4 Global Key Players of Gamma Valerolactone, Industry Ranking, 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Gamma Valerolactone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Gamma Valerolactone, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Gamma Valerolactone, Product Offered and Application
4.8 Global Key Manufacturers of Gamma Valerolactone, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Gamma Valerolactone Sales Quantity by Type
5.1.1 Global Gamma Valerolactone Historical Sales Quantity by Type (2019-2024)
5.1.2 Global Gamma Valerolactone Forecasted Sales Quantity by Type (2025-2030)
5.1.3 Global Gamma Valerolactone Sales Quantity Market Share by Type (2019-2030)
5.2 Global Gamma Valerolactone Revenue by Type
5.2.1 Global Gamma Valerolactone Historical Revenue by Type (2019-2024)
5.2.2 Global Gamma Valerolactone Forecasted Revenue by Type (2025-2030)
5.2.3 Global Gamma Valerolactone Revenue Market Share by Type (2019-2030)
5.3 Global Gamma Valerolactone Price by Type
5.3.1 Global Gamma Valerolactone Price by Type (2019-2024)
5.3.2 Global Gamma Valerolactone Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Gamma Valerolactone Sales Quantity by Application
6.1.1 Global Gamma Valerolactone Historical Sales Quantity by Application (2019-2024)
6.1.2 Global Gamma Valerolactone Forecasted Sales Quantity by Application (2025-2030)
6.1.3 Global Gamma Valerolactone Sales Quantity Market Share by Application (2019-2030)
6.2 Global Gamma Valerolactone Revenue by Application
6.2.1 Global Gamma Valerolactone Historical Revenue by Application (2019-2024)
6.2.2 Global Gamma Valerolactone Forecasted Revenue by Application (2025-2030)
6.2.3 Global Gamma Valerolactone Revenue Market Share by Application (2019-2030)
6.3 Global Gamma Valerolactone Price by Application
6.3.1 Global Gamma Valerolactone Price by Application (2019-2024)
6.3.2 Global Gamma Valerolactone Price Forecast by Application (2025-2030)
7 North America
7.1 North America Gamma Valerolactone Sales by Company
7.1.1 North America Gamma Valerolactone Revenue by Company (2019-2024)
7.1.2 North America Gamma Valerolactone Sales Quantity by Company (2019-2024)
7.2 North America Gamma Valerolactone Market Size by Type
7.2.1 North America Gamma Valerolactone Sales Quantity by Type (2019-2030)
7.2.2 North America Gamma Valerolactone Revenue by Type (2019-2030)
7.3 North America Gamma Valerolactone Market Size by Application
7.3.1 North America Gamma Valerolactone Sales Quantity by Application (2019-2030)
7.3.2 North America Gamma Valerolactone Revenue by Application (2019-2030)
7.4 North America Gamma Valerolactone Market Size by Country
7.4.1 North America Gamma Valerolactone Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 North America Gamma Valerolactone Revenue by Country (2019-2030)
7.4.3 North America Gamma Valerolactone Sales Quantity by Country (2019-2030)
7.4.4 U.S.
7.4.5 Canada
8 Europe
8.1 Europe Gamma Valerolactone Sales by Company
8.1.1 Europe Gamma Valerolactone Sales Quantity by Company (2019-2024)
8.1.2 Europe Gamma Valerolactone Revenue by Company (2019-2024)
8.2 Europe Gamma Valerolactone Market Size by Type
8.2.1 Europe Gamma Valerolactone Sales Quantity by Type (2019-2030)
8.2.2 Europe Gamma Valerolactone Revenue by Type (2019-2030)
8.3 Europe Gamma Valerolactone Market Size by Application
8.3.1 Europe Gamma Valerolactone Sales Quantity by Application (2019-2030)
8.3.2 Europe Gamma Valerolactone Revenue by Application (2019-2030)
8.4 Europe Gamma Valerolactone Market Size by Country
8.4.1 Europe Gamma Valerolactone Revenue by Country: 2019 VS 2023 VS 2030
8.4.2 Europe Gamma Valerolactone Revenue by Country (2019-2030)
8.4.3 Europe Gamma Valerolactone Sales Quantity by Country (2019-2030)
8.4.4 Germany
8.4.5 France
8.4.6 U.K.
8.4.7 Italy
8.4.8 Russia
9 China
9.1 China Gamma Valerolactone Sales by Company
9.1.1 China Gamma Valerolactone Sales Quantity by Company (2019-2024)
9.1.2 China Gamma Valerolactone Revenue by Company (2019-2024)
9.2 China Gamma Valerolactone Market Size by Type
9.2.1 China Gamma Valerolactone Sales Quantity by Type (2019-2030)
9.2.2 China Gamma Valerolactone Revenue by Type (2019-2030)
9.3 China Gamma Valerolactone Market Size by Application
9.3.1 China Gamma Valerolactone Sales Quantity by Application (2019-2030)
9.3.2 China Gamma Valerolactone Revenue by Application (2019-2030)
10 APAC (excluding China)
10.1 APAC Gamma Valerolactone Sales by Company
10.1.1 APAC Gamma Valerolactone Sales Quantity by Company (2019-2024)
10.1.2 APAC Gamma Valerolactone Revenue by Company (2019-2024)
10.2 APAC Gamma Valerolactone Market Size by Type
10.2.1 APAC Gamma Valerolactone Sales Quantity by Type (2019-2030)
10.2.2 APAC Gamma Valerolactone Revenue by Type (2019-2030)
10.3 APAC Gamma Valerolactone Market Size by Application
10.3.1 APAC Gamma Valerolactone Sales Quantity by Application (2019-2030)
10.3.2 APAC Gamma Valerolactone Revenue by Application (2019-2030)
10.4 APAC Gamma Valerolactone Market Size by Region
10.4.1 APAC Gamma Valerolactone Revenue by Region: 2019 VS 2023 VS 2030
10.4.2 APAC Gamma Valerolactone Revenue by Region (2019-2030)
10.4.3 APAC Gamma Valerolactone Sales Quantity by Region (2019-2030)
10.4.4 Japan
10.4.5 South Korea
10.4.6 China Taiwan
10.4.7 Southeast Asia
10.4.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Gamma Valerolactone Sales by Company
11.1.1 Middle East, Africa and Latin America Gamma Valerolactone Sales Quantity by Company (2019-2024)
11.1.2 Middle East, Africa and Latin America Gamma Valerolactone Revenue by Company (2019-2024)
11.2 Middle East, Africa and Latin America Gamma Valerolactone Market Size by Type
11.2.1 Middle East, Africa and Latin America Gamma Valerolactone Sales Quantity by Type (2019-2030)
11.2.2 Middle East, Africa and Latin America Gamma Valerolactone Revenue by Type (2019-2030)
11.3 Middle East, Africa and Latin America Gamma Valerolactone Market Size by Application
11.3.1 Middle East, Africa and Latin America Gamma Valerolactone Sales Quantity by Application (2019-2030)
11.3.2 Middle East, Africa and Latin America Gamma Valerolactone Revenue by Application (2019-2030)
11.4 Middle East, Africa and Latin America Gamma Valerolactone Market Size by Country
11.4.1 Middle East, Africa and Latin America Gamma Valerolactone Revenue by Country: 2019 VS 2023 VS 2030
11.4.2 Middle East, Africa and Latin America Gamma Valerolactone Revenue by Country (2019-2030)
11.4.3 Middle East, Africa and Latin America Gamma Valerolactone Sales Quantity by Country (2019-2030)
11.4.4 Brazil
11.4.5 Mexico
11.4.6 Turkey
11.4.7 Israel
11.4.8 GCC Countries
12 Company Profiles
12.1 Anhui Hyea Aromas
12.1.1 Anhui Hyea Aromas Company Information
12.1.2 Anhui Hyea Aromas Overview
12.1.3 Anhui Hyea Aromas Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.1.4 Anhui Hyea Aromas Gamma Valerolactone Products and Services
12.1.5 Anhui Hyea Aromas Gamma Valerolactone SWOT Analysis
12.1.6 Anhui Hyea Aromas Recent Developments
12.2 Dideu Industries
12.2.1 Dideu Industries Company Information
12.2.2 Dideu Industries Overview
12.2.3 Dideu Industries Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.2.4 Dideu Industries Gamma Valerolactone Products and Services
12.2.5 Dideu Industries Gamma Valerolactone SWOT Analysis
12.2.6 Dideu Industries Recent Developments
12.3 Kunshan Qiandeng Baihua
12.3.1 Kunshan Qiandeng Baihua Company Information
12.3.2 Kunshan Qiandeng Baihua Overview
12.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.3.4 Kunshan Qiandeng Baihua Gamma Valerolactone Products and Services
12.3.5 Kunshan Qiandeng Baihua Gamma Valerolactone SWOT Analysis
12.3.6 Kunshan Qiandeng Baihua Recent Developments
12.4 Zhongyue Aroma
12.4.1 Zhongyue Aroma Company Information
12.4.2 Zhongyue Aroma Overview
12.4.3 Zhongyue Aroma Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.4.4 Zhongyue Aroma Gamma Valerolactone Products and Services
12.4.5 Zhongyue Aroma Gamma Valerolactone SWOT Analysis
12.4.6 Zhongyue Aroma Recent Developments
12.5 Soda Aromatic
12.5.1 Soda Aromatic Company Information
12.5.2 Soda Aromatic Overview
12.5.3 Soda Aromatic Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.5.4 Soda Aromatic Gamma Valerolactone Products and Services
12.5.5 Soda Aromatic Gamma Valerolactone SWOT Analysis
12.5.6 Soda Aromatic Recent Developments
12.6 Inoue Perfumery MFG
12.6.1 Inoue Perfumery MFG Company Information
12.6.2 Inoue Perfumery MFG Overview
12.6.3 Inoue Perfumery MFG Gamma Valerolactone Sales Quantity, Revenue, Price and Gross Margin (2019-2024)
12.6.4 Inoue Perfumery MFG Gamma Valerolactone Products and Services
12.6.5 Inoue Perfumery MFG Gamma Valerolactone SWOT Analysis
12.6.6 Inoue Perfumery MFG Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Gamma Valerolactone Value Chain Analysis
13.2 Gamma Valerolactone Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Gamma Valerolactone Production Mode & Process
13.4 Gamma Valerolactone Sales and Marketing
13.4.1 Gamma Valerolactone Sales Channels
13.4.2 Gamma Valerolactone Distributors
13.5 Gamma Valerolactone Customers
14 Market Dynamics
14.1 Gamma Valerolactone Industry Trends
14.2 Gamma Valerolactone Market Drivers
14.3 Gamma Valerolactone Market Challenges
14.4 Gamma Valerolactone Market Restraints
15 Key Findings
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published Date: 2025-09-12
Pages: 94
USD 2900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-09-12
Pages: 78
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-12
Pages: 136
USD 4900.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published Date: 2025-10-15
Pages: 109
USD 3950.00
(Single User License)
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 135
USD 3950.00
(Single User License)
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-08-07
Pages: 133
USD 2900.00
(Single User License)
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-08-07
Pages: 128
USD 4250.00
(Single User License)
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-07
Pages: 141
USD 4900.00
(Single User License)
The global market for Gamma Valerolactone was valued at US$ 509 million in the year 2024 and is projected to reach a revised size of US$ 651 million by 2031, growing at a CAGR of 1.3% during the forecast period.
Published: 2025-09-12
Pages: 94
The global market for Gamma Valerolactone was estimated to be worth US$ 741 million in 2024 and is forecast to a readjusted size of US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
In 2024, the global market size of Gamma Valerolactone was estimated to be worth US$ 741 million and is forecast to reach approximately US$ 725 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
The global Gamma Valerolactone market size was US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-09-12
Pages: 78
The global Gamma Valerolactone market is projected to grow from US$ 509 million in 2024 to US$ 651 million by 2031, at a CAGR of 1.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-12
Pages: 136
The global market for Gamma Valerolactone was estimated to be worth US$ 509 million in 2024 and is forecast to a readjusted size of US$ 651 million by 2031 with a CAGR of 1.3% during the forecast period 2025-2031.
Published: 2025-10-15
Pages: 109
The global market for Gamma Valerolactone was estimated to be worth US$ 603 million in 2025 and is projected to reach US$ 731 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 135
The global Gamma Valerolactone market was valued at US$ 603 million in 2025 and is anticipated to reach US$ 731 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-08-07
Pages: 133
The global Gamma Valerolactone market size was US$ 603 million in 2025 and is forecast to reach a readjusted size of US$ 731 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-08-07
Pages: 128
The global Gamma Valerolactone market is projected to grow from US$ 603 million in 2025 to US$ 731 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-07
Pages: 141
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report